Fluence Corporation is a global water and wastewater treatment solutions company that specializes in innovative, sustainable, and decentralized treatment technologies. Their core mission is to revolutionize water management by delivering high-quality, cost-effective, and low-footprint treatment solutions for municipal, industrial, and commercial applications worldwide.
The company’s flagship technology is the Membrane Aerated Biofilm Reactor (MABR), a groundbreaking wastewater treatment approach that dramatically improves energy efficiency and nutrient removal. Unlike traditional activated sludge treatment methods, Fluence’s MABR technology provides highly efficient treatment with minimal environmental footprint, offering solutions like Aspiral™ smart containerized plants and SUBRE wastewater treatment upgrades that can be deployed quickly and flexibly.
Fluence also focuses on decentralized and waste-to-energy solutions, enabling customers to treat water and wastewater close to the point of use while converting waste into valuable resources. Their innovative technologies allow industries and municipalities to meet strict environmental regulations, reduce energy consumption, and create sustainable water management systems. By offering modular, scalable solutions that can be customized to specific needs, Fluence is positioning itself as a leader in addressing global water challenges through technological innovation.
Join +20,000 subscribers receiving alerts.
Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.
StockWire X delivers fast, reliable, and actionable insights into significant developments across global markets, with coverage spanning technology, biotechnology, healthcare, financials, and emerging industries. Our mission is to provide clear, data-driven content that empowers investors to identify opportunities and make informed decisions ahead of the market.
Our network spans key financial and investment hubs worldwide, ensuring subscribers receive timely updates on market-moving announcements, news, macroeconomic trends, and corporate developments.
Use of Technology
We harness advanced technologies to enhance the speed, accuracy, and relevance of our reporting.
While technology accelerates our workflow, every piece of content is selected, validated, and published by human professionals, in accordance with best practices for accuracy, transparency, and investor value. This hybrid approach ensures speed without compromising editorial integrity.
Feedback and Accuracy
We are committed to accuracy and fairness in our reporting. If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
StockWire X provides readers with access to market news, educational content, and commentary from financial services professionals, industry experts, and companies (“Contributors”).
StockWire X does not hold an Australian Financial Services Licence (AFSL) and relies on the exemption available under section 911A(2)(eb) of the Corporations Act 2001 (Cth) in respect of any financial product advice provided.
Any advice or information published by StockWire X is general in nature only and has been prepared without taking into account your personal objectives, financial situation, or needs. Before acting on any information, you should consider whether it is appropriate for your circumstances and seek independent, licensed financial advice. You should also obtain and read any relevant Product Disclosure Statement (PDS) or other offer document before making an investment decision.
StockWire X makes no guarantee as to the accuracy, completeness, or timeliness of the information provided, and accepts no responsibility for any loss arising from reliance on it. All content is published in good faith for informational purposes only.
StockWire X may have commercial relationships with some contributors or companies mentioned in our content. Any such relationships will be disclosed where relevant.
If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
